Cite
The KATP Channel Activator Diazoxide Ameliorates Amyloid-β and Tau Pathologies and Improves Memory in the 3xTgAD Mouse Model of Alzheimer's Disease
MLA
Nigel H. Greig, et al. “The KATP Channel Activator Diazoxide Ameliorates Amyloid-β and Tau Pathologies and Improves Memory in the 3xTgAD Mouse Model of Alzheimer’s Disease.” Journal of Alzheimer’s Disease, vol. 22, Oct. 2010, pp. 443–57. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....ba780bf847f5a4bf00c5962b29f07998&authtype=sso&custid=ns315887.
APA
Nigel H. Greig, Dong Liu, Julissa Villarreal, Haiyang Jiang, Mohamed R. Mughal, Debomoy K. Lahiri, Katsutoshi Furukawa, Roy G. Cutler, Michael Pitta, Balmiki Ray, Jong Hwan Lee, & Mark P. Mattson. (2010). The KATP Channel Activator Diazoxide Ameliorates Amyloid-β and Tau Pathologies and Improves Memory in the 3xTgAD Mouse Model of Alzheimer’s Disease. Journal of Alzheimer’s Disease, 22, 443–457.
Chicago
Nigel H. Greig, Dong Liu, Julissa Villarreal, Haiyang Jiang, Mohamed R. Mughal, Debomoy K. Lahiri, Katsutoshi Furukawa, et al. 2010. “The KATP Channel Activator Diazoxide Ameliorates Amyloid-β and Tau Pathologies and Improves Memory in the 3xTgAD Mouse Model of Alzheimer’s Disease.” Journal of Alzheimer’s Disease 22 (October): 443–57. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....ba780bf847f5a4bf00c5962b29f07998&authtype=sso&custid=ns315887.